遗传结构区分全身型幼年特发性关节炎与其他亚型:临床与治疗启示
该研究对来自九个国家、由国际儿童关节炎遗传学联盟收集的770例全身型幼年特发性关节炎(sJIA)患儿进行全基因组关联研究,发现MHC位点和1号染色体一个位点与sJIA关联超过全基因组显著性阈值,另23个新位点提示关联。加权遗传风险评分比较显示sJIA与其他常见JIA亚型无共享遗传结构,支持sJIA为独立疾病过程,提示需不同分类框架及针对其独特遗传和病理通路的治疗研究。
要点
- sJIA与MHC位点及1号染色体位点关联超过全基因组显著性阈值。
- 加权遗传风险评分显示sJIA与其他常见JIA亚型无共享遗传结构。
- sJIA独特遗传结构支持其独立疾病分类及靶向独特通路的治疗方向。
核心结论
- sJIA与其他JIA亚型缺乏共享遗传风险因素,支持sJIA为独特疾病过程并提示不同分类框架。
- 改善sJIA治疗的研究应针对其独特遗传学和特定病理生理通路。
研究设计与样本
- 对国际儿童关节炎遗传学联盟在九个国家收集的770例sJIA患儿进行全基因组关联研究。
- 检测单核苷酸多态性与sJIA的关联,并使用加权遗传风险评分比较sJIA与其他JIA亚型的遗传结构。
主要发现
- 主要组织相容性复合体位点和1号染色体一个位点与sJIA关联超过全基因组显著性阈值。
- 另有23个新位点提示与sJIA关联。
- 遗传和统计方法结合分析未发现sJIA与其他常见JIA亚型之间存在共享遗传结构。
临床怎么用
- sJIA的独特遗传特征支持将其视为独立疾病实体,临床分类时应与其他JIA亚型区分。
- sJIA治疗研究应聚焦其独特遗传背景和特定病理生理通路。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Juvenile idiopathic arthritis (JIA) is a heterogeneous group of conditions unified by the presence of chronic childhood arthritis without an identifiable cause. Systemic JIA (sJIA) is a rare form of JIA characterised by systemic inflammation. sJIA is distinguished from other forms of JIA by unique clinical features and treatment responses that are similar to autoinflammatory diseases. However, approximately half of children with sJIA develop destructive, long-standing arthritis that appears similar to other forms of JIA. Using genomic approaches, we sought to gain novel insights into the pathophysiology of sJIA and its relationship with other forms of JIA. METHODS: We performed a genome-wide association study of 770 children with sJIA collected in nine countries by the International Childhood Arthritis Genetics Consortium. Single nucleotide polymorphisms were tested for association with sJIA. Weighted genetic risk scores were used to compare the genetic architecture of sJIA with other JIA subtypes. RESULTS: The major histocompatibility complex locus and a locus on chromosome 1 each showed association with sJIA exceeding the threshold for genome-wide significance, while 23 other novel loci were suggestive of association with sJIA. Using a combination of genetic and statistical approaches, we found no evidence of shared genetic architecture between sJIA and other common JIA subtypes. CONCLUSIONS: The lack of shared genetic risk factors between sJIA and other JIA subtypes supports the hypothesis that sJIA is a unique disease process and argues for a different classification framework. Research to improve sJIA therapy should target its unique genetics and specific pathophysiological pathways.
引用
- Ombrello MJ, Arthur VL, Remmers EF, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2016. PMID: 27927641. doi:10.1136/annrheumdis-2016-210324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。